• OPEN AN ACCOUNT
Indian Indices
Nifty
24,853.15 243.45
(0.99%)
Sensex
81,721.08 769.09
( 0.95%)
Bank Nifty
55,398.25 456.95
( 0.83%)
Nifty IT
37,403.55 353.45
( 0.95%)
Global Indices
Nasdaq
41,619.71 -260.38
(-0.62%)
Dow Jones
5,822.92 -40.09
(-0.68%)
Hang Seng
37,152.02 166.15
(0.45%)
Nikkei 225
8,717.97 -21.29
(-0.24%)
Forex
USD-INR
85.87 0.29
(0.34%)
EUR-INR
97.05 0.10
(0.11%)
GBP-INR
115.23 0.36
(0.31%)
JPY-INR
0.60 0.00
(0.46%)

EQUITY - MARKET SCREENER

Aristo Bio-Tech & Lifescience Ltd
Industry :  Pesticides / Agrochemicals - Indian
BSE Code
ISIN Demat
Book Value()
76744
INE082101010
49.367784
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ARISTO
21.68
84.42
EPS(TTM)
Face Value()
Div & Yield %
5.72
10
0.32
 

ashok leyl& ltd
Ashok Leyland gains as total sales rises 6% YoY in Mar’25
Apr 01,2025
The company’s total domestic sales jumped 6.24% YoY to 22,510 units in the month of March.

Domestic sales of medium and heavy commercial vehicles (M&HCV) advanced 11.78% to 16,082 units, while sales of light commercial vehicles (LCV) fell by 5.47% to 6,428 units in March 2025 compared to March 2024.

Ashok Leyland is engaged in the manufacture and sale of a wide range of commercial vehicles. The company also manufactures engines for industrial and marine applications, forgings, and castings.

The company’s consolidated net profit surged 36% to Rs 761.92 crore in Q3 FY25 as against Rs 560.21 crore posted in Q3 FY24. Revenue from operations rose 8.2% to Rs 11,946.15 crore in the quarter ended 31 December 2024.